pharmaceuticals

white pills

Why AbbVie Earnings Failed to Impress Investors

AbbVie Inc. (NYSE: ABBV) reported its first-quarter financial results before the markets opened on Thursday. The company said it had $1.15 in earnings per share (EPS) on $5.96 billion in ...
Read Full Story »
Prescription drugs

Major Pharma Short Interest Remains Mixed, With 1 Massive Drop

The short interest data have been released for the April 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
100 dollar bills

Why Global Pharma Profits Should Keep Rising

With  2016 being a U.S. presidential election year, there has been an endless debate over drug pricing and the government's lack of ability to negotiate with drug companies. If Moody's ...
Read Full Story »
FDA_logo

Why This Isn’t the End of Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX) saw its shares get halved just Tuesday morning alone, following a business update regarding its Lambert-Eaton myasthenic syndrome (LEMS) treatment. The company provided an update ...
Read Full Story »
Test tubes

4 Biotechs That Will Escape Weak Seasonal Trends for the Sector

All sectors of the market tend to have times of the year that are better than others, and biotechnology is no different. Typically each year, the first quarter is the ...
Read Full Story »
Prescription Drugs, Pills

The World’s 15 Top Selling Drugs

Attaining a certain drug can mean the difference between life and death for millions of Americans. These essential products also help generate billions for drug manufacturers. Pharmaceutical companies generate an ...
Read Full Story »
Medicine pills

What to Expect When Eli Lilly Reports Earnings

Eli Lilly and Co. (NYSE: LLY) is set to release its first-quarter earnings report before the markets open on Tuesday. Thomson Reuters has consensus estimates of $0.85 in earnings per share ...
Read Full Story »
U Turn

Could This Be the Turnaround That Aralez Pharma Is Looking For?

Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) saw its stock take a solid uptick early on Monday following a key approval in Canada. After a very rough past year, this could be beginning ...
Read Full Story »
Female patient on gurney

Why Key Analyst Sees Huge Upside in Sarepta Therapeutics

Sarepta Therapeutics Inc. (NASDAQ: SRPT) saw its shares get crushed on Thursday and then explode on Friday following the U.S. Food and Drug Administration (FDA) view on its Duchenne muscular ...
Read Full Story »
graph

Parnell Pharma Soars on Business Update

Parnell Pharmaceuticals Holding Ltd. (NASDAQ: PARN) saw its shares take a sharp uptick into the weekend following a solid business update. The company announced business results for the first quarter of ...
Read Full Story »
graph

Spectrum Pharma Jumps on FDA Orphan Designation

Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI) saw its shares rise early on Wednesday after earning an Orphan designation. The company announced that the U.S. Food and Drug Administration (FDA) Office of Orphan ...
Read Full Story »
FDA_logo

Cara Therapeutics Rises on FDA Judgment

Cara Therapeutics Inc. (NASDAQ: CARA) saw its shares jump early on Wednesday after the U.S. Food and Drug Administration (FDA) made a favorable judgment for them. The company announced that ...
Read Full Story »
clinical trials

Gemphire Therapeutics Gears Up for IPO

Gemphire Therapeutics has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were given in the filing, but the ...
Read Full Story »
white pills

Biotech and Pharmaceuticals Highlight Jefferies Top Growth Stock Buys

With earnings season hitting its stride this week, many investors are looking to see how the companies they own perform. Two areas that have lagged all year long are biotech ...
Read Full Story »
FDA_logo

Are Analysts Realistic on Clovis Oncology Now?

Clovis Oncology Inc. (NASDAQ: CLVS) was down about 5% Tuesday and was down even more Wednesday after the Oncologic Drugs Advisory Committee voted against its lung cancer drug. The committee ...
Read Full Story »